These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1164008)

  • 1. Effects of renal failure and dialysis on cefazolin pharmacokinetics.
    Madhavan T; Yaremchuk K; Levin N; Fisher E; Cox F; Burch K; Haas E; Pohlod D; Quinn EL
    Antimicrob Agents Chemother; 1975 Jul; 8(1):63-6. PubMed ID: 1164008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefazolin in patients with renal failure; special reference to hemodialysis.
    Brogard JM; Pinget M; Brandt C; Lavillaureix J
    J Clin Pharmacol; 1977 Apr; 17(4):225-30. PubMed ID: 849996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.
    Ahern MJ; Finkelstein FO; Andriole VT
    Antimicrob Agents Chemother; 1976 Sep; 10(3):457-61. PubMed ID: 984787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and hemodialyzability of cefazolin in uremic patients.
    Craig CP; Rifkin SI
    Clin Pharmacol Ther; 1976 Jun; 19(6):825-9. PubMed ID: 773590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of intraperitoneal cefazolin in patients undergoing peritoneal dialysis.
    Kaye D; Wenger N; Agarwal B
    Antimicrob Agents Chemother; 1978 Sep; 14(3):318-21. PubMed ID: 708010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.
    Srinivasan S; Fu KP; Neu HC
    Antimicrob Agents Chemother; 1981 Feb; 19(2):302-5. PubMed ID: 6214989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
    Srinivasan S; Neu HC
    Antimicrob Agents Chemother; 1981 Sep; 20(3):398-400. PubMed ID: 6458236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefamandole in patients with renal failure.
    Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1977 Feb; 11(2):248-50. PubMed ID: 848929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moxalactam pharmacokinetics during hemodialysis.
    Aronoff GR; Sloan RS; Mong SA; Luft FC; Kleit SA
    Antimicrob Agents Chemother; 1981 Apr; 19(4):575-7. PubMed ID: 6454386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
    Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion.
    Polk RE; Kline BJ; Markowitz SM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):576-9. PubMed ID: 6459759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.
    Andriole VT
    J Infect Dis; 1978 May; 137 Suppl():S88-S99. PubMed ID: 349098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of cefazolin and other cephalosporins in patients with renal insufficiency.
    Craig WA; Welling PG; Jackson TC; Kunin CM
    J Infect Dis; 1973 Oct; 128():Suppl:S347-5. PubMed ID: 4744016
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis.
    Tourkantonis A; Nicolaidis P
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():263-7. PubMed ID: 6352629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ceforanide in patients with end stage renal disease on hemodialysis.
    Hess JR; Berman SJ; Boughton WH; Sugihara JG; Musgrave JE; Wong EG; Siemsen AM
    Antimicrob Agents Chemother; 1980 Feb; 17(2):251-3. PubMed ID: 7387145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.
    Lee FH; Pfeffer M; Van Harken DR; Smyth RD; Hottendorf GH
    Antimicrob Agents Chemother; 1980 Feb; 17(2):188-92. PubMed ID: 7387141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J; Francke EL; Saltzman M; Neu HC
    Ther Drug Monit; 1981; 3(1):71-4. PubMed ID: 6262952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency.
    Bolton WK; Scheld WM; Spyker DA; Sande MA
    Antimicrob Agents Chemother; 1981 May; 19(5):821-5. PubMed ID: 6457558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, distribution and elimination of cefazolin in patients with normal renal function.
    Bergan T; Digranes A; Schreiner A
    Chemotherapy; 1978; 24(5):277-82. PubMed ID: 352636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefazolin in children with renal insufficiency.
    Hiner LB; Baluarte HJ; Polinsky MS; Gruskin AB
    J Pediatr; 1980 Feb; 96(2):335-9. PubMed ID: 7351609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.